Successful resolution of refractory chronic cough induced by gastroesophageal reflux with treatment of baclofen

Cough

Volumn 8, Issue 1, 2012, Pages

  Xu, Xianghuai ^a   Chen, Qiang ^a   Liang, Siwei ^a   LÜ, Hanjing ^a   Qiu, Zhongmin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Baclofen; Chronic cough; Gastroesophageal reflux; Multi channel intraluminal impedance combined with pH monitoring

Indexed keywords

EID: 84867555205     PISSN: None     EISSN: 17459974     Source Type: Journal    
DOI: 10.1186/1745-9974-8-8     Document Type: Article

References (14)

1. Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 2006, 129:80S-94S. 10.1378/chest.129.1_suppl.80S, 16428697.
2. Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2010, 32:334-343. 10.1111/j.1365-2036.2010.04358.x, 20491749.
3. Patterson RN, Johnston BT, MacMahon J, Heaney LG, McGarvey LP. Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough". Eur Respir J 2004, 24:724-727. 10.1183/09031936.04.00007404, 15516662.
4. Tsoukali E, Sifrim D. The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled?. J Neurogastroenterol Motil 2010, 16:258-264. 10.5056/jnm.2010.16.3.258, 2912118, 20680164.
5. Boeckxstaens GE. Reflux inhibitors: a new approach for GERD?. Curr Opin Pharmacol 2008, 8:685-689. 10.1016/j.coph.2008.08.005, 18771751.
6. Beaumont H, Boeckxstaens GE. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?. Am J Gastroenterol 2009, 104:1764-1771. 10.1038/ajg.2009.247, 19491837.
7. Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002, 50:19-24. 10.1136/gut.50.1.19, 1773078, 11772961.
8. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects. Gastroenterology 2000, 118:7-13. 10.1016/S0016-5085(00)70408-2, 10611148.
9. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastroesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003, 17:243-251. 10.1046/j.1365-2036.2003.01394.x, 12534409.
10. Bolser DC, Aziz SM, DeGennaro FC, Kreutner W, Egan RW, Siegel MI, Chapman RW. Antitussive effects of GABAB agonists in the cat and guinea-pig. Br J Pharmacol 1993, 110:491-495. 10.1111/j.1476-5381.1993.tb13837.x, 2175970, 8220912.
11. Dicpinigaitis PV, Dobkin JB. Antitussive effect of the GABA-agonist baclofen. Chest 1997, 111:996-999. 10.1378/chest.111.4.996, 9106580.
12. Dicpinigaitis PV, Dobkin JB, Rauf K, Aldrich TK. Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol 1998, 38:364-367.
13. Dicpinigaitis PV. Use of baclofen to suppress cough induced by angiotensin-converting enzyme inhibitors. Ann Pharmacother 1996, 30:1242-1245.
14. Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration 1998, 65:86-88. 10.1159/000029232, 9523374.